The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
fda pi zhun northera yong yu zhi liao shen jing yuan xing ti wei xing di xue ya
Pages: 194
Year: Issue:  3
Journal: World Clinical Drugs

Keyword:  体位性低血压FDANorthera神经源性多系统萎缩罕见病用药共同性问题帕金森病临床症状临床试验;
Abstract: <正>近日,美国FDA批准罕见病用药droxidopa(Northera)用于治疗神经源性体位性低血压(NOH)。NOH是一种罕见的慢性直立性低血压,这种疾病与帕金森病、多系统萎缩及单纯性自主神经衰竭相关,主要临床症状包括头晕、头昏眼花、视力模糊、疲劳及站立时晕倒。本品经FDA快速审批通道获批,本品上市说明书添加有一项黑框警告:有仰卧时血压升高(体位性高血压)的风险,这也是影响原发性自主神经衰竭患者的一个共同性问题,同时还可引起中风。值得注意的是,
Related Articles
No related articles found